Business NewsPR NewsWire • Oncopeptides AB: Interim Report Q2 2019

Oncopeptides AB: Interim Report Q2 2019

Oncopeptides AB: Interim Report Q2 2019

STOCKHOLM, Aug. 28, 2019 /PRNewswire/ -- Summary Financial overview April 1 – June 30, 2019 Net sales amounted to SEK 0.0 M (0.0) Loss for the period was SEK 171.9 M (loss: 144.6) Loss per share, before and after dilution, was SEK 3.52 (loss: 3.30) On June 30 cash and cash equivalents...

View More : https://www.prnewswire.com:443/news-releases/oncopeptides-ab-interim-report-q2-2019-300908267.html
Releted News by prnewswire
Weltwasserwoche beginnt mit Aufrufen zu Maßnahmen für Gleichstellung beim Thema Wasser
Medivir AB - Interim Report January - June 2019
Australierin Macinley Butson mit Stockholm Junior Water Prize 2019 ausgezeichnet
Oncopeptides AB: Interim Report Q2 2019
Luye Pharma First Half of 2019 Results: Strong Revenue Growth and Substantial Development of R&D Product Pipelines